DouglasNeyMD(He/Him)

Neurooncology

Professor, Neurology and Neurosurgery, University of Colorado School of Medicine Vice-Chair Education, Department of Neurology

Join to view full profile

Dr. Ney is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ney's full profile

Already have an account?

Office
12631 E. 17th Avenue
Academic Office 1, MS B185
Aurora, CO 80045
Phone+1 303-724-2184

Fax+1 303-724-2213

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Neuro-Oncology, 2007 - 2009
University of Vermont Medical CenterResidency, Neurology, 2004 - 2007
University of Vermont Medical CenterInternship, Internal Medicine, 2003 - 2004
University of Rochester School of Medicine and DentistryClass of 2003

Certifications & Licensure

CO State Medical License 2009 - 2025
NY State Medical License 2007 - 2011
VT State Medical License 2003 - 2007
American Board of Psychiatry and Neurology Neurology
United Council of Neurologic SubspecialtiesCertification in Neuro-Oncology

Awards, Honors, & Recognition

Fellow AAN
5280 Top Doc 5280 Magazine, 2019
Academy of Medical Educators University of Colorado School of Medicine, 2018
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Join now to see all

Clinical Trials

A Dose Per Fraction Escalation Trial of Hypofractionated IMRT With Temozolomide for Newly Diagnosed Glioblastoma Start of enrollment: 2005 Nov 01
Completed
Phase 1
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) Start of enrollment: 2009 Jun 01
Completed
Phase 3
Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme Start of enrollment: 2010 Sep 16
Completed
Phase 2
Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma Start of enrollment: 2013 Jun 01
Active, not recruiting
Not Applicable
Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme Start of enrollment: 2014 May 01
Completed
Phase 1, Phase 2
Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response Start of enrollment: 2016 Jul 12
Terminated
Phase 2
Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma Start of enrollment: 2017 Dec 07
Active, not recruiting
Phase 2
A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma Start of enrollment: 2017 Jul 24
Completed
Phase 1, Phase 2
Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma Start of enrollment: 2019 Jun 17
Recruiting
Phase 1, Phase 2
Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients Start of enrollment: 2016 Jul 01
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

12 citations
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers.
Kevin A David, Suchitra Sundaram, Seo-Hyun Kim, Ryan Vaca, Yong Lin
American Journal of Hematology. 2023-06-01
2 citations
EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort.
Prashasti Agrawal, Kevin A David, Zhengming Chen, Suchitra Sundaram, Seo-Hyun Kim
Leukemia & Lymphoma. 2023-05-01
ANA Investigates: The Future of Biomarkers in Alzheimer Disease.
Suzanne E Schindler, Douglas E Ney, Adeline L Goss, Gil Rabinovici
Annals of Neurology. 2022-08-01

Journal Articles

The Neurologic Assessment in Neuro-Oncology (NANO) Scale as an Assessment Tool for Survival in Patients with Primary Glioblastoma
Denise Damek, Kevin O Lillehei, D Ryan Ormond, Chad G Rusthoven, A Samy Youssef, Timothy H Ung, Douglas E Ney, Neurosurgery